Filing Details

Accession Number:
0001144204-14-014246
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-03-07 19:29:02
Reporting Period:
2014-03-05
Filing Date:
2014-03-07
Accepted Time:
2014-03-07 19:29:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1088856 Corcept Therapeutics Inc CORT Pharmaceutical Preparations (2834) 770487658
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1419701 L.p. Partners Venture Longitude 800 El Camino Real
Suite 220
Menlo Park CA 94025
Yes No Yes No
1430719 Longitude Capital Associates, L.p. 800 El Camino Real
Suite 220
Menlo Park CA 94025
No No Yes No
1430720 Longitude Capital Partners, Llc 800 El Camino Real
Suite 220
Menlo Park CA 94025
No No Yes No
1431159 Juliet Bakker Tammenoms Longitude Capital Management Co., Llc
800 El Camino Real, Suite 220
Menlo Park CA 94025
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-03-05 70,063 $4.01 13,175,781 No 4 S Direct
Common Stock Disposition 2014-03-05 1,404 $4.01 186,325 No 4 S Direct
Common Stock Disposition 2014-03-06 164,800 $4.00 13,010,981 No 4 S Direct
Common Stock Disposition 2014-03-06 3,303 $4.00 183,022 No 4 S Direct
Common Stock Disposition 2014-03-07 10,225 $4.00 13,000,756 No 4 S Direct
Common Stock Disposition 2014-03-07 205 $4.00 182,817 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. Reflects sales of common stock executed in multiple transactions at prices ranging from $4.00 to $4.07. The price reported reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, Corcept Therapeutics Incorporated or a security holder of Corcept Therapeutics Incorporated full information regarding the number of shares and prices at which the sales were effected.
  2. Does not include warrants held by Longitude Venture Partners, L.P. ("LVP") to purchase 3,091,479 shares of common stock.
  3. Reflects transactions and holdings of shares of common stock of the Issuer held of record by LVP. This report is filed jointly by LVP, Longitude Capital Partners, LLC ("Longitude Capital") and Juliet Tammenoms Bakker, all of whom share beneficial ownership of more than 10% of the capital stock of the Issuer, with respect to the securities held and transactions effected by LVP. LVP may also be deemed a director by virtue of its right to nominate a representative to serve on the Issuer's Board of Directors. Patrick G. Enright currently serves as LVP's representative on the Issuer's Board of Directors. Each of Longitude Capital and Ms. Tammenoms Bakker disclaims beneficial ownership of these securities except to the extent of their respective pecuniary interest therein.
  4. Does not include warrants held by Longitude Capital Associates, L.P. ("LCA") to purchase 26,583 shares of common stock.
  5. Reflects transactions and holdings of shares of common stock held of record by LCA. This report is jointly filed by LCA, Longitude Capital and Juliet Tammenoms Bakker, all of whom share beneficial ownership of more than 10% of the capital stock of the Issuer, with respect to the securities held and transactions effected by LCA. Each of Longitude Capital and Ms. Tammenoms Bakker disclaims beneficial ownership of these securities except to the extent of their respective pecuniary interest therein.
  6. Reflects sales of common stock executed in multiple transactions at prices ranging from $4.00 to $4.01. The price reported reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, Corcept Therapeutics Incorporated or a security holder of Corcept Therapeutics Incorporated full information regarding the number of shares and prices at which the sales were effected.